The EU MDR certification is a significant regulatory achievement for ClearPoint Neuro, as it demonstrates compliance with stringent European standards. This could potentially enhance the company's marketability and competitiveness in the European market, likely leading to positive investor sentiment and a short-term increase in stock price.